Cargando…

Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa

BACKGROUND: Substance use and psychiatric disorders cause significant burden of disease in low- and middle-income countries. Co-morbid psychopathology and longer duration of untreated psychosis (DUP) can negatively affect treatment outcomes. OBJECTIVES: The study assessed substance use amongst adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Glen P., Tomita, Andrew, Baumgartner, Joy Noel, Mtshemla, Sisanda, Nene, Siphumelele, King, Howard, Susser, Ezra, Burns, Jonathan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904841/
https://www.ncbi.nlm.nih.gov/pubmed/27307782
http://dx.doi.org/10.4102/sajpsychiatry.v22i1.852
_version_ 1782437204511948800
author Davis, Glen P.
Tomita, Andrew
Baumgartner, Joy Noel
Mtshemla, Sisanda
Nene, Siphumelele
King, Howard
Susser, Ezra
Burns, Jonathan K.
author_facet Davis, Glen P.
Tomita, Andrew
Baumgartner, Joy Noel
Mtshemla, Sisanda
Nene, Siphumelele
King, Howard
Susser, Ezra
Burns, Jonathan K.
author_sort Davis, Glen P.
collection PubMed
description BACKGROUND: Substance use and psychiatric disorders cause significant burden of disease in low- and middle-income countries. Co-morbid psychopathology and longer duration of untreated psychosis (DUP) can negatively affect treatment outcomes. OBJECTIVES: The study assessed substance use amongst adults with severe mental illness receiving services at a regional psychiatric hospital in KwaZulu-Natal (South Africa). We describe the prevalence and correlates of lifetime substance use and examine the association between substance use and DUP. METHODS: A cross-sectional survey recruited adults diagnosed with severe mental illness and assessed lifetime and past 3-month substance use using the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test. Regression analyses were conducted to determine associations between lifetime substance use (other than alcohol and tobacco) and DUP as measured by the World Health Organization Encounter Form. RESULTS: Amongst 87 participants, alcohol (81.6%), tobacco (75.6%) and cannabis (49.4%) were the most common substances reported for lifetime use. Risk of health-related problems (health, social, financial, legal and relationship) of cannabis use was associated with younger age, single marital status and lower education. Adjusted regression analyses indicated that use of amphetamines and methaqualone is associated with longer DUP. CONCLUSIONS: Substance use is prevalent amongst psychiatric patients in KwaZulu-Natal and may contribute to longer DUP. Mental health services in this region should address co-morbid substance use and psychiatric disorders.
format Online
Article
Text
id pubmed-4904841
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher AOSIS
record_format MEDLINE/PubMed
spelling pubmed-49048412016-06-13 Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa Davis, Glen P. Tomita, Andrew Baumgartner, Joy Noel Mtshemla, Sisanda Nene, Siphumelele King, Howard Susser, Ezra Burns, Jonathan K. S Afr J Psychiatr Original Research BACKGROUND: Substance use and psychiatric disorders cause significant burden of disease in low- and middle-income countries. Co-morbid psychopathology and longer duration of untreated psychosis (DUP) can negatively affect treatment outcomes. OBJECTIVES: The study assessed substance use amongst adults with severe mental illness receiving services at a regional psychiatric hospital in KwaZulu-Natal (South Africa). We describe the prevalence and correlates of lifetime substance use and examine the association between substance use and DUP. METHODS: A cross-sectional survey recruited adults diagnosed with severe mental illness and assessed lifetime and past 3-month substance use using the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test. Regression analyses were conducted to determine associations between lifetime substance use (other than alcohol and tobacco) and DUP as measured by the World Health Organization Encounter Form. RESULTS: Amongst 87 participants, alcohol (81.6%), tobacco (75.6%) and cannabis (49.4%) were the most common substances reported for lifetime use. Risk of health-related problems (health, social, financial, legal and relationship) of cannabis use was associated with younger age, single marital status and lower education. Adjusted regression analyses indicated that use of amphetamines and methaqualone is associated with longer DUP. CONCLUSIONS: Substance use is prevalent amongst psychiatric patients in KwaZulu-Natal and may contribute to longer DUP. Mental health services in this region should address co-morbid substance use and psychiatric disorders. AOSIS 2016-05-20 /pmc/articles/PMC4904841/ /pubmed/27307782 http://dx.doi.org/10.4102/sajpsychiatry.v22i1.852 Text en © 2016. The Authors http://creativecommons.org/licenses/by/2.0/ Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
spellingShingle Original Research
Davis, Glen P.
Tomita, Andrew
Baumgartner, Joy Noel
Mtshemla, Sisanda
Nene, Siphumelele
King, Howard
Susser, Ezra
Burns, Jonathan K.
Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa
title Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa
title_full Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa
title_fullStr Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa
title_full_unstemmed Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa
title_short Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa
title_sort substance use and duration of untreated psychosis in kwazulu-natal, south africa
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904841/
https://www.ncbi.nlm.nih.gov/pubmed/27307782
http://dx.doi.org/10.4102/sajpsychiatry.v22i1.852
work_keys_str_mv AT davisglenp substanceuseanddurationofuntreatedpsychosisinkwazulunatalsouthafrica
AT tomitaandrew substanceuseanddurationofuntreatedpsychosisinkwazulunatalsouthafrica
AT baumgartnerjoynoel substanceuseanddurationofuntreatedpsychosisinkwazulunatalsouthafrica
AT mtshemlasisanda substanceuseanddurationofuntreatedpsychosisinkwazulunatalsouthafrica
AT nenesiphumelele substanceuseanddurationofuntreatedpsychosisinkwazulunatalsouthafrica
AT kinghoward substanceuseanddurationofuntreatedpsychosisinkwazulunatalsouthafrica
AT susserezra substanceuseanddurationofuntreatedpsychosisinkwazulunatalsouthafrica
AT burnsjonathank substanceuseanddurationofuntreatedpsychosisinkwazulunatalsouthafrica